Shigella species are Gram negative bacilli (rods) and are part of the Family Enterobacteriaceae. Other Family members include Escherichia coli (E. coli), Klebsiella species, Enterobacter species, Citrobacter species, and Salmonella species. There are 4 species of Shigella: S. sonnei, S. flexneri, S. dysenteriae, and S. boydii. S. dysenteriae is considered the most virulent. It can produce a potent cytotoxin known as Shiga-toxin.
Shigella bacteria will cause an infectious diarrheal illness referred to as Shigellosis. The bacteria is acid-tolerant, so only a few bacteria need to pass through the stomach to cause illness.
Shigella bacteria spread through the direct or indirect fecal-oral route. The illness is highly infectious and can also be spread from person to person. Transmission typically occurs by:
The incubation period for shigellosis is 1 to 7 days.
Once ingested, Shigella causes watery diarrhea, usually occurring within 24 to 48 hours. Illness can range from mild, watery diarrhea to a severe inflammatory infection referred to as dysentery. Symptoms include:
The illness usually lasts for 4 to 7 days. People are infectious while they are sick, and infectivity could last for up to 4 weeks after illness. Some people may not experience symptoms after they have been infected with Shigella. However, their feces may still be contagious for up to a few weeks.
Complications occasionally include:
Infections are usually self-limiting (assuming oral rehydration or electrolyte replacement). Infection can become life-threatening in seniors, children and those with weakened immune systems. In severe cases, patients may need to be given fluids intravenously.
Most patients recover without complications within 5 to 7 days without specific treatment.
Antibiotics are prescribed based on the severity of disease, the age of the patient and the likelihood of further transmission of the infection. Many strains of Shigella have developed resistance to multiple antibiotics. In this situation, laboratory tests are required to determine which antibiotics are likely to be effective. Extensively drug-resistant (XDR) Shigella is being monitored as an increasing number of resistant isolated have been noted over the past few years. (https://emergency.cdc.gov/han/2023/pdf/CDC_HAN_486.pdf)
CDC and Health Canada do not recommend specific transmission-based precautions for Shigella in continent adults, however, when caring for children, or adults with uncontrolled diarrhea, use of the appropriate transmission-based precautions would be indicated.
Other measures to prevent transmission would include:
Diversey has several disinfectants effective against Shigella species.
These include:

Shigella
Centers for Disease Control: https://www.cdc.gov/shigella/index.html
Health Canada: https://www.canada.ca/en/public-health/services/diseases/shigella.html
Reviewed/Revised March 1, 2023